A broad collection of peer-reviewed studies ties these GLP-1 receptor agonists to significant, long-lasting weight loss in adults who find their weight hard to control
Discussing your specific surgical date and type with a provider experienced in post-bariatric care ensures safe timing for GLP-1 therapy initiation
Policy and Clinical Standards (For Consideration) While I am not a lawyer, I believe it is important for the plan sponsor to be aware of the evolving policy and clinical standards related to obesity care, which increasingly recognize obesity as a chronic disease requiring evidence-based treatment
Further, clinical trials show that long-acting GLP-1 medicines decrease cardiovascular events in individuals with T2D or obesity
Eli Lillys orforglipron continues to advance but has not yet reached benchmark weight loss efficacy
Retatrutide, scientifically known as LY3437943 , is a novel peptide designed for therapeutic applications